One platform, three formats.
iCann Fast
Fast-dissolving sublingual tablet. Designed for rapid absorption through the oral mucosa.
5 to 10 min
Onset
About 2.5 hrs
Duration
iCann Oral
Immediate-release oral capsule. Designed for controlled absorption through the digestive tract.
About 20 min
Onset
3 to 4 hrs
Duration
iCann LA
Long-acting mucoadhesive buccal tablet. Designed for sustained release over several hours.
About 45 min
Onset
8+ hrs
Duration
Company-reported, format-specific timing. Individual response varies; request supporting product data.
WHAT EVERY ICANN PRODUCT SHARES
Built on the same standards.
NanoVATE Delivery™
Higher bioavailability and more consistent absorption than standard cannabis oil, as reported in IMCI’s formulation studies.
Full-spectrum extracts
The platform carries the whole extract, not only isolated cannabinoids.
Pharma-grade components
Formulated, specified and tested to pharma-grade standards, and designed for EU-GMP manufacturing.
HOW ICANN REACHES THE MARKET
A supply route for each market.
iCann is offered as final dosage forms, magistral preparations or premix, according to each market’s regulation.
iCann products are supplied only within each market’s medical cannabis framework, to licensed partners and on prescription where required.
GET IN TOUCH
Let’s talk.
Physician, pharmacist, distributor or investor, tell us what you need and the right person on our team will follow up.
IMCI Pharmaceuticals is a commercial-stage pharmaceutical company. Product availability and regulatory status vary by market. Information on this website is not medical advice.